Illumina shares a professor's perspective on shaping new technology
Exeter University Prof. Emma Baple discusses her research on pediatric rare disease and the opportunity to shape new technology.
See the latest news and media coverage for Illumina. We track all announcements, press releases, and industry mentions in real time, all in one place.
Genomic sequencing and array technology company
illumina.comLast updated
Exeter University Prof. Emma Baple discusses her research on pediatric rare disease and the opportunity to shape new technology.
The updates aim to scale proteomics for integration with sequencing, enhancing precision medicine.
It expands tissue analysis, tumor microenvironment study, and drug target identification.
A pediatric expert in Taiwan uses it to interpret previously difficult-to-diagnose cases.
New insider activity at Illumina ( ($ILMN) ) has taken place on June 1, 2026. Illumina insiders have recently executed notable stock sales involving two...
Private funds advised by Corvex sold 669,596 Illumina shares between May 28 and June 1 at about $147.50–$165.50 and terminated equity swaps on 24,562 shares.
A DNA sequencing startup will have to rejigger its antitrust lawsuit against Illumina after a California federal judge said it hasn't shown that the industry...
/PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced the launch of the StrataMap Spatial Solution, offering an unmatched breadth of coverage and...
Track Illumina and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.